More details on this developing story will follow.
UBS raises Revolution stock price target to $265 on drug pricing
By Investing.com News • Published earlier today
Source: Investing.com News
LATEST
Flash floods in Nepal: 320 Indians missing✦How Chennai’s Neurostellar is measuring the mental stamina of Chess players✦Naidu calls for effective implementation of constituency-level vision action plans✦BioLineRx targets $3.75M raise via direct offering with new ADS warrants✦Roborock’s new robot vacuum is so hands-off, you might forget it’s there✦
Dhallo News